In the week of July 21, 2025, 12 holders filed a new Schedule 13D and 78 a new Schedule 13G reporting 5% or more of a company, and 1 13D filing stated an intent to influence the company. The largest stake reported that week is Northrop Grumman Pension Master Trust's 100% of EP Private Capital Fund I (Schedule 13G, July 25, 2025).
New 13D12
New 13G78
Stated intents1
The week of 2025-07-21, 12 holders filed a new Schedule 13D and 78 a new Schedule 13G reporting 5% or more of a company, and 1 13D filing stated in Item 4 an intent to influence the company. Open a company for every holder and the purpose each 13D states, quoted.
New Schedule 13D
| Filed | Company | Holder | Percent | Filing |
|---|---|---|---|---|
| 2025-07-25 | Tron Inc. | Bravemorning Limited | 95.93% | SCHEDULE 13D |
| 2025-07-25 | Anghami Inc. | Warner Bros. Discovery, Inc. | 70.8% | SCHEDULE 13D |
| 2025-07-22 | LakeShore Biopharma Co., Ltd. | Crystal Peak Investment Inc. | 51% | SCHEDULE 13D |
| 2025-07-22 | Crisp Momentum Inc. | Jakota Games & Reels SAS | 50.7% | SCHEDULE 13D |
| 2025-07-21 | Solarius Capital Acquisition Corporation | Solarius Capital Sponsor, LLC | 26.44% | SCHEDULE 13D |
| 2025-07-25 | Vista Credit Strategic Lending Corp. | Nonghyup Bank as trustee of DBAM Vista Credit Investment Trust No. 2 | 20.1% | SCHEDULE 13D |
| 2025-07-23 | TIAN RUIXIANG Holdings Ltd | Medata Holdings Limited | 16.68% | SCHEDULE 13D |
| 2025-07-22 | DallasNews Corp | MNG Enterprises, Inc. | 9.9% | SCHEDULE 13D |
| 2025-07-24 | Electra Battery Materials Corp | Highbridge Capital Management, LLC | 9.9% | SCHEDULE 13D |
| 2025-07-24 | Electra Battery Materials Corp | Whitebox Advisors LLC | 9.9% | SCHEDULE 13D |
| 2025-07-24 | The Mexico Fund, Inc. | Saba Capital Management, L.P. | 8.35% | SCHEDULE 13D |
| 2025-07-24 | Empery Digital Inc. | Empery Asset Management, LP | 5.83% | SCHEDULE 13D |
New Schedule 13G
| Filed | Company | Holder | Percent | Filing |
|---|---|---|---|---|
| 2025-07-25 | EP Private Capital Fund I | Northrop Grumman Pension Master Trust | 100% | SCHEDULE 13G |
| 2025-07-23 | LandBridge Corp | Horizon Kinetics Asset Management LLC | 23.6% | SCHEDULE 13G |
| 2025-07-22 | Carlyle Credit Income Fund | Eagle Point Credit Management LLC | 19.07% | SCHEDULE 13G |
| 2025-07-24 | Alpha Tau Medical Ltd. | Uzi Sofer | 15.8% | SCHEDULE 13G |
| 2025-07-25 | Streamex Corp. | Avanico Limited | 12.13% | SCHEDULE 13G |
| 2025-07-24 | TIAN RUIXIANG Holdings Ltd | Lan Cheng | 11.7% | SCHEDULE 13G |
| 2025-07-25 | Namib Minerals | Hennessy Capital Partners VI LLC | 11% | SCHEDULE 13G |
| 2025-07-22 | Upexi, Inc. | MMCAP International Inc. SPC | 9.99% | SCHEDULE 13G |
| 2025-07-24 | Profusa, Inc. | Ascent Partners Fund LLC | 9.99% | SCHEDULE 13G |
| 2025-07-25 | 3 E Network Technology Group Limited | L1 Capital Global Opportunities Master Fund, Ltd. | 9.99% | SCHEDULE 13G |
| 2025-07-21 | Silver Pegasus Acquisition Corp. | Harraden Circle Investments, LLC | 9.9% | SCHEDULE 13G |
| 2025-07-21 | Milestone Pharmaceuticals Inc. | Trails Edge Capital Partners, LP | 9.9% | SCHEDULE 13G |
| 2025-07-22 | DallasNews Corp | Beryl Capital Management LLC | 9.9% | SCHEDULE 13G |
| 2025-07-22 | 60 Degrees Pharmaceuticals, Inc. | CVI Investments, Inc. | 9.9% | SCHEDULE 13G |
| 2025-07-24 | Garden Stage Ltd | Streeterville Capital LLC | 9.9% | SCHEDULE 13G |
| 2025-07-25 | Contineum Therapeutics, Inc. | RA Capital Management, L.P. | 9.9% | SCHEDULE 13G |
| 2025-07-22 | Future FinTech Group Inc. | Jian Ke | 9.85% | SCHEDULE 13G |
| 2025-07-22 | RTB Digital, Inc. | Arena Investors, LP | 8.7% | SCHEDULE 13G |
| 2025-07-23 | Radiopharm Theranostics Limited | Regal Funds Management Pty Limited | 7.3% | SCHEDULE 13G |
| 2025-07-23 | TOMI Environmental Solutions, Inc. | Morgan Stephen L. | 7.3% | SCHEDULE 13G |
| 2025-07-21 | Wintergreen Acquisition Corp. | Wolverine Asset Management LLC | 7.25% | SCHEDULE 13G |
| 2025-07-22 | Praxis Precision Medicines Inc. | Perceptive Advisors LLC | 6.69% | SCHEDULE 13G |
| 2025-07-21 | Silver Pegasus Acquisition Corp. | Harraden Circle Investments, LLC | 6.65% | SCHEDULE 13G |
| 2025-07-24 | Cantor Equity Partners Iii, Inc. | Harraden Circle Investments, LLC | 6.65% | SCHEDULE 13G |
| 2025-07-23 | Comerica Inc | Integrated Core Strategies (US) LLC | 6.6% | SCHEDULE 13G |
| 2025-07-23 | Aris Water Solutions, Inc. | Horizon Kinetics Asset Management LLC | 6.4% | SCHEDULE 13G |
| 2025-07-23 | Pyrophyte Acquisition Corp. II | Millennium Management LLC | 6.4% | SCHEDULE 13G |
| 2025-07-23 | Bridge Investment Group Holdings Inc. | Glazer Capital, LLC | 6.38% | SCHEDULE 13G |
| 2025-07-21 | Shoe Station Group Inc | Copeland Capital Management, LLC | 6.28% | SCHEDULE 13G |
| 2025-07-24 | Pb Bankshares Inc | Jacobs Asset Management, LLC | 6.18% | SCHEDULE 13G |
| 2025-07-21 | Silver Pegasus Acquisition Corp. | Linden Capital L.P. | 6.1% | SCHEDULE 13G |
| 2025-07-23 | Tejon Ranch Co. | Horizon Kinetics Asset Management LLC | 6.1% | SCHEDULE 13G |
| 2025-07-23 | Iperionx Ltd | Regal Funds Management Pty Limited | 5.92% | SCHEDULE 13G |
| 2025-07-21 | Lakeland Financial Corp | Neuberger Berman Group LLC | 5.9% | SCHEDULE 13G |
| 2025-07-24 | Carlsmed, Inc. | Michael Cordonnier | 5.9% | SCHEDULE 13G |
| 2025-07-25 | Vivid Seats Inc. | Emeth Value Capital, LLC | 5.9% | SCHEDULE 13G |
| 2025-07-21 | Auna, S.A. | Bank Of Nova Scotia | 5.85% | SCHEDULE 13G |
| 2025-07-21 | US Physical Therapy Inc | Copeland Capital Management, LLC | 5.85% | SCHEDULE 13G |
| 2025-07-24 | HilleVax, Inc. | EcoR1 Capital, LLC | 5.8% | SCHEDULE 13G |
| 2025-07-22 | BriaCell Therapeutics Corp. | CVI Investments, Inc. | 5.7% | SCHEDULE 13G |
| 2025-07-21 | Flaherty & Crumrine Preferred and Income Securities Fund Incorporated | First Trust Portfolios L.P. | 5.65% | SCHEDULE 13G |
| 2025-07-23 | MVB Financial Corp | Bay Pond Partners, L.P. | 5.6% | SCHEDULE 13G |
| 2025-07-24 | UY Scuti Acquisition Corp. | Wolverine Asset Management LLC | 5.55% | SCHEDULE 13G |
| 2025-07-25 | Niocorp Developments Ltd | Kenneth Griffin | 5.4% | SCHEDULE 13G |
| 2025-07-23 | BlackRock Floating Rate Income Strategies Fund, Inc. | First Trust Portfolios L.P. | 5.37% | SCHEDULE 13G |
| 2025-07-22 | DarioHealth Corp. | Titan Trust 2024 I | 5.32% | SCHEDULE 13G |
| 2025-07-22 | AngioDynamics, Inc. | Millennium Management LLC | 5.3% | SCHEDULE 13G |
| 2025-07-22 | BTC Digital Ltd. | CVI Investments, Inc. | 5.3% | SCHEDULE 13G |
| 2025-07-23 | Immersion Corp | Irrevocable Larson Family Investment Trust | 5.3% | SCHEDULE 13G |
| 2025-07-25 | HarborOne Bancorp Inc | Glazer Capital, LLC | 5.3% | SCHEDULE 13G |
| 2025-07-22 | Hingham Institution for Savings | Royce & Associates LP | 5.29% | SCHEDULE 13G |
| 2025-07-21 | VanEck Oil Refiners ETF | First Trust Portfolios L.P. | 5.25% | SCHEDULE 13G |
| 2025-07-24 | Sable Offshore Corp. | Encompass Capital Advisors LLC | 5.24% | SCHEDULE 13G |
| 2025-07-22 | Abrdn Japan Equity Fund, Inc. | Css LLC | 5.21% | SCHEDULE 13G |
| 2025-07-22 | GameSquare Holdings, Inc. | CVI Investments, Inc. | 5.2% | SCHEDULE 13G |
| 2025-07-22 | Suncor Energy Inc | BlackRock, Inc. | 5.2% | SCHEDULE 13G |
| 2025-07-22 | Ares Management Corp | BlackRock, Inc. | 5.2% | SCHEDULE 13G |
| 2025-07-24 | Caredx, Inc. | Neil Gagnon | 5.2% | SCHEDULE 13G |
| 2025-07-21 | Future Vision II Acquisition Corp. | Wolverine Asset Management LLC | 5.17% | SCHEDULE 13G |
| 2025-07-24 | BridgeBio Oncology Therapeutics, Inc. | Sculptor Capital LP | 5.12% | SCHEDULE 13G |
| 2025-07-23 | Amplify Energy Corp. | Irrevocable Larson Family Investment Trust | 5.1% | SCHEDULE 13G |
| 2025-07-24 | Dun & Bradstreet Holdings, Inc. | Glazer Capital, LLC | 5.1% | SCHEDULE 13G |
| 2025-07-25 | iTeos Therapeutics, Inc. | Ridgeback Capital Investments L.P. | 5.1% | SCHEDULE 13G |
| 2025-07-25 | Sarepta Therapeutics, Inc. | D. E. Shaw & Co., L.P. | 5.1% | SCHEDULE 13G |
| 2025-07-21 | Graf Global Corp. | Wolverine Asset Management LLC | 5.09% | SCHEDULE 13G |
| 2025-07-21 | Range Capital Acquisition Corp | Wolverine Asset Management LLC | 5.09% | SCHEDULE 13G |
| 2025-07-22 | NWPX Infrastructure Inc | Royce & Associates LP | 5.08% | SCHEDULE 13G |
| 2025-07-22 | Lakeshore Acquisition III Corp. | Shaolin Capital Management LLC | 5.05% | SCHEDULE 13G |
| 2025-07-23 | BlackRock Corporate High Yield Fund, Inc. | First Trust Portfolios L.P. | 5.05% | SCHEDULE 13G |
| 2025-07-21 | Agricultural & Natural Solutions Acquisition Corporation | Wolverine Asset Management LLC | 5.03% | SCHEDULE 13G |
| 2025-07-25 | BrasilAgro - Brazilian Agricultural Real Estate Co | Kopernik Global Investors, LLC | 5.03% | SCHEDULE 13G |
| 2025-07-21 | Newbury Street II Acquisition Corp | Wolverine Asset Management LLC | 5.02% | SCHEDULE 13G |
| 2025-07-22 | Stoneridge Inc | Royce & Associates LP | 5.02% | SCHEDULE 13G |
| 2025-07-24 | Fortive Corp | Viking Global Investors LP | 5.02% | SCHEDULE 13G |
| 2025-07-24 | Atour Lifestyle Holdings Limited | OceanLink Partners Fund, LP | 5.02% | SCHEDULE 13G |
| 2025-07-22 | Teva Pharmaceutical Industries Ltd. | Phoenix Financial Ltd. | 5% | SCHEDULE 13G |
| 2025-07-24 | Silver Pegasus Acquisition Corp. | Harraden Circle Investments, LLC | 5% | SCHEDULE 13G |
| 2025-07-24 | Pyrophyte Acquisition Corp. II | Harraden Circle Investments, LLC | 5% | SCHEDULE 13G |
Stated intent
| Filed | Company | Holder | Percent | Filing |
|---|---|---|---|---|
| 2025-07-21 | LEE ENTERPRISES, Inc | Jerrilyn M. Hoffmann Revocable Trust dated May 30, 2001 intent stated | 9.99% | SCHEDULE 13D/A |
Download this data (CSV)91 rows, with sources. Free with an account.
Tools for this story
Each opens in a new tab. With no account yet, you sign up free and land on the result.
Where this comes from
Anyone who comes to own more than 5% of a class of a listed company's voting shares has to tell the SEC. A holder who may seek to change or influence the company files Schedule 13D, and has to say in Item 4, "Purpose of Transaction", what it intends to do. A holder with no such intent, such as many index and passive funds, may file the shorter Schedule 13G. Both are amended when the stake changes, including when it falls below 5%.
Every row here is one of those filings, linked to the filing itself. Percentages and share counts are exactly as the holder filed them, for the holder the filing names; an amendment showing a lower figure is shown as filed. Item 4 text is quoted word for word. Where a 13D's Item 4 contains a sentence stating a definite intent to influence the company, that sentence is marked and quoted; the page does not describe the holder or its motives beyond the words it filed. Nothing here is investment advice.